Sanmina Corp. Hits New 52-Week High, Surging 291.88% in a Year

Sanmina Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by hitting a new 52-week high of USD 262.69 on May 26, 2026. This achievement underscores the company's impressive performance over the past year, with a remarkable return of 291.88%, significantly outpacing the S&P 500's return of 29.58%. The company's market capitalization stands at USD 12,249 million, reflecting its solid position within the industry. Sanmina Corp. boasts a price-to-earnings (P/E) ratio of 39.00, indicating a fair valuation relative to its peers. Additionally, the company maintains a low debt-to-equity ratio of 0.31, showcasing its financial stability. With a return on equity (ROE) of 12.64%, Sanmina Corp. demonstrates high management efficiency. The stock's price-to-book ratio of 4.95 further supports its valuation metrics. Despite facing some challenges, including a 10.99% increase in raw material costs year-over-year, the company has shown resilience and strong institutional support, with holdings at 100%. This combination of factors positions Sanmina Corp. favorably in the current market landscape.